Company intelligence / Profile preview

MLS Capital Fund II

Malaysia

Ownership: Private
Development stage: Other

Overview

MLS Capital Fund II is a biogreentech-focused venture/private equity fund co-managed by Spruce Capital Partners and Xeraya Capital, investing globally across plant and animal agriculture, food, feed, nutrition, bio-renewable chemicals and materials, and related enabling technologies such as synthetic biology, data analytics, and robotics.

Industry: Investors

Partnerships

Spruce Capital Partners (co-manager)Xeraya Capital (co-manager)

Beyond the preview

Go deeper on MLS Capital Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MLS Capital Fund II.

Explore the full profile